A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP

Name: A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP
Published: 2018
License: Public Domain

Novartis Pharmaceuticals · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

bleeding immune platelets

immune thrombocytopenic purpura (itp), thrombocytopenic, immune, platelets, bleeding, itp, eltrombopag, etb115, induce sustained response off treatment, refractory or relapsed, first-line steroids, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP

Related documents